Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
Hayashi K, Katano Y, Kuzuya T, Tachi Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H.
J Med Virol. 2012 Mar;84(3):438-44. doi: 10.1002/jmv.23207.
Related citations
Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
Chary A, Winters MA, Eisen R, Knight TH, Asmuth DM, Holodniy M.
J Med Virol. 2012 Mar;84(3):431-7. doi: 10.1002/jmv.23210.
Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.
Blackard JT, Ma G, Welge JA, Martin CM, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ.
J Med Virol. 2012 Feb;84(2):242-52. doi: 10.1002/jmv.22269.
Demographics, socio-behavioral factors, and drug use patterns: what matters in spontaneous HCV clearance?
Shah DP, Grimes CZ, Brown E, Hwang LY.
J Med Virol. 2012 Feb;84(2):235-41. doi: 10.1002/jmv.22271.
A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization.
Sasayama M, Shoji I, Adianti M, Jiang DP, Deng L, Saito T, Watanabe H, Kawata S, Aoki C, Hotta H.
J Med Virol. 2012 Feb;84(2):229-34. doi: 10.1002/jmv.22257.
Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island.
Karatapanis S, Tsoplou P, Papastergiou V, Vasiageorgi A, Stampori M, Saitis I, Tsitsopoulos E, Lisgos P, Skorda L, Ketikoglou I, Goulis I.
J Med Virol. 2012 Feb;84(2):223-8. doi: 10.1002/jmv.22249.
Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b.
Toyoda H, Kumada T, Tada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F.
J Med Virol. 2012 Jan;84(1):61-70. doi: 10.1002/jmv.22272.
Human platelet antigen genotype is associated with progression of fibrosis in chronic hepatitis C.
Silva GF, Grotto RM, Verdichio-Moraes CF, Corvino SM, Ferrasi AC, Silveira LV, Pardini MI.
J Med Virol. 2012 Jan;84(1):56-60. doi: 10.1002/jmv.22191.
Near-full genome characterization of unclassified hepatitis C virus strains relating to genotypes 1 and 4.
Demetriou VL, Kostrikis LG.
J Med Virol. 2011 Dec;83(12):2119-27. doi: 10.1002/jmv.22237.
Transmission of hepatitis C virus among spouses in Cameroon and the Central African Republic.
Njouom R, Lavoie M, Foupouapouognigni Y, Frost E, Deslandes S, Mamadou-Yaya F, Mbélesso P, Mbadingai S, Pépin J.
J Med Virol. 2011 Dec;83(12):2113-8. doi: 10.1002/jmv.22225.
Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan.
Gasim GI, Hamdan HZ, Hamdan SZ, Adam I.
J Med Virol. 2012 Jan;84(1):52-5. doi: 10.1002/jmv.22256. Epub 2011 Nov 3.
Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.
Wu S, Liu Y, Cheng L, Yin B, Peng J, Sun Z.
J Med Virol. 2011 Nov;83(11):1930-7. doi: 10.1002/jmv.22168.
Prevalence of amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors.
Furui Y, Hoshi Y, Murata K, Ito K, Suzuki K, Uchida S, Satake M, Mizokami M, Tadokoro K.
J Med Virol. 2011 Nov;83(11):1924-9. doi: 10.1002/jmv.22216.
Seroprevalence of HIV, syphilis, and hepatitis C virus in the general population of the Liangshan Prefecture, Sichuan Province, China.
Dai S, Shen Z, Zha Z, Leng R, Qin W, Wang C, Chen L, Tian M, Huang Z, Chen G, Cen H, Xue L, Wang J, Lu Y, Cao B, Ye D.
J Med Virol. 2012 Jan;84(1):1-5. doi: 10.1002/jmv.22214. Epub 2011 Oct 25.
Acute hepatitis C in Brazil: results of a national survey.
Ferreira Ade S, Perez Rde M, Ferraz ML, Lewis-Ximenez LL, Pereira JL, de Almeida PR, de Mattos AA; Acute Hepatitis C Study Group of The Brazilian Society of Hepatology.
J Med Virol. 2011 Oct;83(10):1738-43. doi: 10.1002/jmv.22175.
Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.
Yokozaki S, Katano Y, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Goto H.
J Med Virol. 2011 Oct;83(10):1727-32. doi: 10.1002/jmv.21959.
Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users.
Ciccozzi M, Zehender G, Cento V, Lo Presti A, Teoharov P, Pavlov I, Bogdanova V, Perno CF, Ciotti M.
J Med Virol. 2011 Sep;83(9):1565-70. doi: 10.1002/jmv.22154.
Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene.
Toyoda H, Kumada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F.
J Med Virol. 2011 Sep;83(9):1559-64. doi: 10.1002/jmv.22145.
Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.
Abe H, Hayes CN, Ochi H, Tsuge M, Miki D, Hiraga N, Imamura M, Takahashi S, Kubo M, Nakamura Y, Kamatani N, Chayama K.
J Med Virol. 2011 Sep;83(9):1597-607. doi: 10.1002/jmv.22158.
Mutations in the E2 and NS5A regions in patients infected with hepatitis C virus genotype 1a and their correlation with response to treatment.
Yahoo N, Sabahi F, Shahzamani K, Malboobi MA, Jabbari H, Sharifi H, Mousavi-Fard SH, Merat S.
J Med Virol. 2011 Aug;83(8):1332-7. doi: 10.1002/jmv.22144.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on